300009.SZ
Price:
$9.77
Market Cap:
$16.34B
Anhui Anke Biotechnology (Group) Co., Ltd. develops, produces, and markets pharmaceutical products in China and internationally. The company offers recombinant human growth hormone for injection under the Ansomone name; and recombinant human interferon alpha 2b lyophilized powder, liquid, and prefilled syringe for injection, as well as recombinant human interferon alpha 2b cream, eye drop, and suppository under the Anterferon name. It also provides anti-sperm antibody, semen leukocyte peroxidase staining, one-time semen processing, sperm hypo-osmotic staining, sperm life detection, sperm staining detection, sperm acrosin detection, sperm DNA fragmentation staining, and leptin and immunohisto...[Read more]
Industry
Biotechnology
IPO Date
2009-10-30
Stock Exchange
SHZ
Ticker
300009.SZ
According to Anhui Anke Biotechnology (Group) Co., Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 16.20B. This represents a change of 13.03% compared to the average of 14.34B of the last 4 quarters.
The mean historical Enterprise Value of Anhui Anke Biotechnology (Group) Co., Ltd. over the last ten years is 15.96B. The current 16.20B Enterprise Value has changed 10.05% with respect to the historical average. Over the past ten years (40 quarters), 300009.SZ's Enterprise Value was at its highest in in the June 2021 quarter at 23.86B. The Enterprise Value was at its lowest in in the December 2016 quarter at 10.82B.
Average
15.96B
Median
15.82B
Minimum
11.28B
Maximum
21.15B
Discovering the peaks and valleys of Anhui Anke Biotechnology (Group) Co., Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 225.74%
Maximum Annual Enterprise Value = 21.15B
Minimum Annual Increase = -30.80%
Minimum Annual Enterprise Value = 11.28B
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 14.29B | -13.36% |
| 2023 | 16.49B | 9.81% |
| 2022 | 15.02B | -29.01% |
| 2021 | 21.15B | 6.80% |
| 2020 | 19.80B | 29.06% |
| 2019 | 15.34B | 21.37% |
| 2018 | 12.64B | -26.97% |
| 2017 | 17.31B | 53.50% |
| 2016 | 11.28B | -30.80% |
| 2015 | 16.30B | 225.74% |
The current Enterprise Value of Anhui Anke Biotechnology (Group) Co., Ltd. (300009.SZ) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
15.26B
5-year avg
17.35B
10-year avg
15.96B
Anhui Anke Biotechnology (Group) Co., Ltd.’s Enterprise Value is less than Yunnan Botanee Bio-Technology Group Co.LTD (16.58B), less than Mabwell (Shanghai) Bioscience Co., Ltd. (16.71B), less than DaShenLin Pharmaceutical Group Co., Ltd. (25.81B), greater than Staidson (Beijing) BioPharmaceuticals Co., Ltd. (12.68B), greater than Zhejiang Jiuzhou Pharmaceutical Co., Ltd (13.51B), less than Inner Mongolia Furui Medical Science Co., Ltd. (18.76B), less than Apeloa Pharmaceutical Co.,Ltd (18.68B), greater than Tonghua Dongbao Pharmaceutical Co., Ltd. (15.59B), greater than Tibet Cheezheng Tibetan Medicine Co., Ltd. (13.61B), greater than Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (14.04B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 16.58B | $17.18B | |
| 16.71B | $15.52B | |
| 25.81B | $20.78B | |
| 12.68B | $12.79B | |
| 13.51B | $15.88B | |
| 18.76B | $19.23B | |
| 18.68B | $19.24B | |
| 15.59B | $16.30B | |
| 13.61B | $12.82B | |
| 14.04B | $15.07B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Anhui Anke Biotechnology (Group) Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Anhui Anke Biotechnology (Group) Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Anhui Anke Biotechnology (Group) Co., Ltd.'s Enterprise Value?
What is the highest Enterprise Value for Anhui Anke Biotechnology (Group) Co., Ltd. (300009.SZ)?
What is the 3-year average Enterprise Value for Anhui Anke Biotechnology (Group) Co., Ltd. (300009.SZ)?
What is the 5-year average Enterprise Value for Anhui Anke Biotechnology (Group) Co., Ltd. (300009.SZ)?
How does the current Enterprise Value for Anhui Anke Biotechnology (Group) Co., Ltd. (300009.SZ) compare to its historical average?